SEARCH

SEARCH BY CITATION

References

  • Armengaud J, Cristie-Oleza JA, Clair G, Malard V & Duport C (2012) Exoproteomics: exploring the world around the biological systems. Expert Rev Proteomics 9: 561575.
  • Ashford DA, di Pietra J, Lingappa J et al. (2004) Adverse events in humans associated with accidental exposure to livestock brucellosis vaccine RB51. Vaccine 22: 34353439.
  • Barh D, Barve N, Gupta K et al. (2013) Exoproteome and secretome derived broad spectrum novel drug and vaccine candidates in Vibrio cholerae targeted by Piper betel derived compounds. PLoS One 8: e52773.
  • Cassataro J, Estein SM, Pasquevich KA, Velikovsky CA, de la Barrera S, Bowden R, Fossati CA & Giambartolomei GH (2005) Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection. Infect Immun 73: 80798088.
  • Connolly JP, Comerci D, Alefantis TG, Walz A, Quan M, Chafin R, Grewal P, Mujer CV, Ugalde RA & DelVecchio VG (2006) Proteomic analysis of Brucella abortus cell envelope and identification of immunogenic candidate proteins for vaccine development. Proteomics 6: 37673780.
  • Corbel MJ (1976) The immunological properties of Brucella ribosomal preparations. Dev Biol Stand 31: 115122.
  • Corbel MJ (1997) Brucellosis: an overview. Emerg Infect Dis 3: 213221.
  • Delpino MV, Estein SM, Fossati CA, Baldi PC & Cassataro J (2007) Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice. Vaccine 25: 67216729.
  • Delpino VM, Comerci DJ, Wagner MA, Eschenbrenner M, Mujer CV, Ugalde RA, Fossati CA, Baldi PC & Delvecchio VG (2009) Differential composition of culture supernatants from wild-type Brucella abortus and isogenic virB mutants. Arch Microbiol 191: 571581.
  • Dhanwani R, Khan M, Alam SI, Rao PV & Parida M (2011) Differential proteomic analysis of Chikungunya virus-infected new-born mice tissue reveal implication of stress, inflammatory and apoptotic pathways in disease pathogenesis. Proteomics 11: 19361951.
  • Dumas E, Desvaux M, Chambon C & Hébraud M (2009) Insight into the core and variant exoproteomes of Listeria monocytogenes species by comparative subproteomic analysis. Proteomics 9: 31363155.
  • Garmory HS & Titball RW (2004) ATP-binding cassette transporters are targets for the development of antibacterial vaccines and therapies. Infect Immun 72: 67576763.
  • Goel D & Bhatnagar R (2012) Intradermal immunization with outer membrane protein 25 protects Balb/c mice from virulent B. abortus 544. Mol Immunol 51: 159168.
  • Henderson B & Martin A (2011) Bacterial virulence in the moonlight: multitasking bacterial moonlighting proteins are virulence determinants in infectious disease. Infect Immun 79: 34763491.
  • Kumar S, Balakrishna K, Agarwal GS, Merwyn S, Rai GP, Batra HV, Sardesai AA & Gowrishankar J (2009) Th1-type immune response to infection by pYV-cured phoP–phoQ null mutant of Yersinia pseudotuberculosis is defective in mouse model. Antonie Van Leeuwenhoek 95: 91100.
  • Leclerq S, Harms JS, Rosinha GM, Azevedo V & Oliveira SC (2002) Induction of a Th1-type of immune response but not protective immunity by intramuscular DNA immunisation with Brucella abortus GroEL heat-shock gene. J Med Microbiol 51: 2026.
  • Mallick AI, Singha H, Khan S, Anwar T, Ansari MA, Khalid R, Chaudhuri P & Owais M (2007) Escheriosome-mediated delivery of recombinant ribosomal L7/L12 protein confers protection against murine brucellosis. Vaccine 25: 78737884.
  • Mao S, Luo Y, Zhang T, Li J, Bao G, Zhu Y, Chen Z, Zhang Y, Li Y & Ma Y (2010) Proteome reference map and comparative proteomic analysis between a wild type Clostridium acetobutylicum DSM 1731 and its mutant with enhanced butanol tolerance and butanol yield. J Proteome Res 9: 30463061.
  • Murphy EA, Sathiyaseelan J, Parent MA, Zou B & Baldwin CL (2001) Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice. Immunology 103: 511518.
  • Oliveira SC & Splitter GA (1996) Immunization of mice recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection. Vaccine 14: 959962.
  • Oliveira SC, Zhu Y & Splitter GA (1994) Recombinant L7/L12 ribosomal protein and gamma-irradiated Brucella abortus induce a T-helper 1 subset response from murine CD4+ T cells. Immunology 83: 659664.
  • Oliveira SC, Harms JS, Rech EL, Rodarte RS, Bocca AL, Goes AM & Splitter GA (1998) The role of T cell subsets and cytokines in the regulation of an intracellular bacterial infection. Braz J Med Biol Res 32: 7784.
  • Pappas G, Panagopoulou P, Christou L & Akritidis N (2006) Brucella as a biological weapon. Cell Mol Life Sci 63: 22292236.
  • Paranavitana C, Zelazowska E, Izadjoo M & Hoover D (2005) Interferon-γ associated cytokines and chemokines produced by spleen cells from Brucella-immune mice. Cytokine 30: 8692.
  • Pasquevich KA, Estein SM, García Samartino C, Zwerdling A, Coria LM, Barrionuevo P, Fossati CA, Giambartolomei GH & Cassataro J (2009) Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection. Infect Immun 77: 436445.
  • Perkins SD, Smither SJ & Atkins HS (2010) Towards a Brucella vaccine for humans. FEMS Microbiol Rev 34: 379394.
  • Rosinha GM, Freitas DA, Miyoshi A, Azevedo V, Campos E, Cravero SL, Rossetti O, Splitter G & Oliveira SC (2002) Identification and characterization of a Brucella abortus ATP-binding cassette transporter homolog to Rhizobium meliloti ExsA and its role in virulence and protection in mice. Infect Immun 70: 50365044.
  • Sambrook J & Russell DW (2001) Molecular Cloning: A Laboratory Manual, 3rd edn, Vol. 1. CSHL Press, New York.
  • Schurig GG, Roop RM II, Bagchi T, Boyle S, Buhrman D & Sriranganathan N (1991) Biological properties of RB51: a stable rough strain of Brucella abortus. Vet Microbiol 28: 171188.
  • Schurig GG, Sriranganathan N & Corbel MJ (2002) Brucellosis vaccines: past, present and future. Vet Microbiol 90: 479496.
  • Sengupta N, Alam SI, Kumar B, Kumar RB, Gautam V, Kumar S & Singh L (2010) Comparative proteomic analysis of extracellular proteins of Clostridium perfringens type A and type C strains. Infect Immun 78: 39573968.
  • Silva TM, Paixao TA, Costa EA et al. (2011) Putative ATP-binding cassette transporter is essential for Brucella ovis pathogenesis in mice. Infect Immun 79: 17061717.
  • Sinha S, Kosalai K, Arora S, Namane A, Sharma P, Gaikwad AN, Brodin P & Cole ST (2005) Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics. Microbiology 151: 24112419.
  • Stevens MG, Hennager SG, Olsen SC & Cheville NF (1994) Serologic responses in diagnostic tests for brucellosis in cattle vaccinated with Brucella abortus 19 or RB51. J Clin Microbiol 32: 10651066.
  • Tiwari AK, Kumar S, Pal V, Bhardwaj B & Rai GP (2011) Evaluation of the recombinant 10-kilodalton immunodominant region of the BP26 protein of Brucella abortus for specific diagnosis of bovine brucellosis. Clin Vaccine Immunol 18: 17601764.
  • Tjalsma H, Antelmann H, Jongbloed JD et al. (2004) Proteomics of protein secretion by Bacillus subtilis: separating the “secrets” of the secretome. Microbiol Mol Biol Rev 68: 207233.
  • Velikovsky CA, Goldbaum FA, Cassataro J, Estein S, Bowden RA, Bruno L, Fossati CA & Giambartolomei GH (2003) Brucella lumazine synthase elicits a mixed Th1–Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulations used. Infect Immun 71: 57505755.
  • Vrioni G, Pappas G, Priavali E, Gartzonika C & Levidiotou S (2008) An eternal microbe: Brucella DNA load persists for years after clinical cure. Clin Infect Dis 46: e131e136.
  • Yang Y, Yin J, Guo D, Lang X & Wang X (2011) Immunization of mice with recombinant S –adenosyl-L—homocysteine hydrolase protein confers protection against Brucella melitensis infection. FEMS Immunol Med Microbiol 61: 159167.